It is driven by the rising prevalence of musculoskeletal disorders. The global lumbosacral orthosis (LSO) market is projected to reach $595.4m by 2030 at a compound annual growth rate of 3.5% ...

There is, for example, a crucial difference as to whether a lordosing or delordosing lumbar orthosis is prescribed for zygapophyseal joint syndrome (facet syndrome). Often, chronic, non-specific ...